Alchornea glandulosa Ethyl Acetate Fraction Exhibits Antiangiogenic Activity: Preliminary Findings from In Vitro Assays Using Human Umbilical Vein Endothelial Cells

dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorMascia Lopes, Flavia Cristine
dc.creatorRocha, Ana
dc.creatorPirraco, Ana
dc.creatorRegasini, Luis O.
dc.creatorSiqueira, Janaina R.
dc.creatorSilva, Dulce Helena Siqueira
dc.creatorBolzani, Vanderlan da Silva
dc.creatorCarlos, Iracilda Z.
dc.creatorSoares, Raquel
dc.date2014-05-20T14:21:09Z
dc.date2016-10-25T17:41:53Z
dc.date2014-05-20T14:21:09Z
dc.date2016-10-25T17:41:53Z
dc.date2011-10-01
dc.date.accessioned2017-04-05T22:35:33Z
dc.date.available2017-04-05T22:35:33Z
dc.identifierJournal of Medicinal Food. New Rochelle: Mary Ann Liebert Inc., v. 14, n. 10, p. 1244-1253, 2011.
dc.identifier1096-620X
dc.identifierhttp://hdl.handle.net/11449/26325
dc.identifierhttp://acervodigital.unesp.br/handle/11449/26325
dc.identifier10.1089/jmf.2010.0204
dc.identifierWOS:000295950000021
dc.identifierWOS000295950000021.pdf
dc.identifierhttp://dx.doi.org/10.1089/jmf.2010.0204
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/871066
dc.descriptionAlchornea glandulosa has traditionally been used in Brazilian folk medicine for the treatment of immune-inflammatory diseases and as an antiulcer agent to heal gastric ulcer and gastritis. Angiogenesis is a complex multistep process that consists of proliferation, migration, and anastomosis of endothelial cells and has a major role in the development of pathologic conditions, such as inflammatory diseases. To investigate a possible link between the anti-inflammatory activities and antiangiogenic effects of A. glandulosa ethyl acetate fraction (AGF), this study examined which features of the angiogenic process could be disturbed by this fraction. The antiangiogenic activity of AGF was determined in vitro by using human umbilical vein endothelial cells (HUVEC), and cell viability, proliferation, apoptosis, invasion, and capillary-like structures formation were addressed. To elucidate the mechanism of action, nuclear factor kappa B (NF kappa B), a transcription factor implicated in these processes, was also evaluated in HUVEC incubated with AGF. A significant decrease in proliferation, a relevant increase in apoptosis, and a strong reduction in invasion capacity (as assessed by bromodeoxyuridine, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling, and double-chamber assays, respectively) were observed. AGF also led to a drastic reduction in the number of capillary-like structures formed when HUVEC were cultured on growth factor-reduced Matrigel-coated plates. In addition, incubation of HUVEC with AGF resulted in reduced NF kappa B activity. These findings emphasize the antiangiogenic potential of AGF and support its therapeutic use for disorders that involve excessive angiogenesis, such as chronic inflammation and tumor growth.
dc.descriptionCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.languageeng
dc.publisherMary Ann Liebert, Inc.
dc.relationJournal of Medicinal Food
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAlchornea glandulosa
dc.subjectantiangiogenic
dc.subjectethyl acetate fraction
dc.subjecthuman umbilical vein endothelial cells
dc.subjectnuclear factor kappa B
dc.titleAlchornea glandulosa Ethyl Acetate Fraction Exhibits Antiangiogenic Activity: Preliminary Findings from In Vitro Assays Using Human Umbilical Vein Endothelial Cells
dc.typeOtro


Este ítem pertenece a la siguiente institución